featured
Oral Nirmatrelvir–Ritonavir as Postexposure Prophylaxis for Patients With COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19
N. Engl. J. Med 2024 Jul 18;391(3)224-234, J Hammond, C Yunis, RJ Fountaine, G Luscan, AM Burr, W Zhang, W Wisemandle, H Soares, ML Baniecki, VM Hendrick, V Kalfov, R Pypstra, JM RusnakFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.